Respiratory Care Devices Market (2026 - 2035)

Respiratory Care Devices Market Research Report By Device Type (Therapeutic Devices, Monitoring Devices, Diagnostic Devices, Consumables), By Application (Chronic Obstructive Pulmonary Disease, Asthma, Sleep Apnea, Respiratory Distress Syndrome), By End Use (Hospitals, Homecare, Ambulatory Care Centers, Emergency Medical Services), By Patient Type (Pediatric, Adult, Geriatric) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Industry Forecast to 2035
ID: MRFR/MED/5055-HCR
128 Pages
Rahul Gotadki, Kinjoll Dey
Last Updated: July 17, 2026
Respiratory Care Devices Market
Market Size
Forecast Period2026-2035
CAGR (2026-2035)7.8%
2025 Market SizeUSD 24.8 Billion
2035 Market SizeUSD 52.3 Billion
Key Players
Medtronic
ResMed
Philips Respironics
Drägerwerk
GE Healthcare
Fisher & Paykel Healthcare
Trends
  • Disease Burden and Screening Expansion
  • Homecare Shift and Reimbursement Reform
  • Connected Device Innovation
Opportunities
  • Connected Remote Monitoring
  • Emerging Market Expansion
  • Data and Subscription-Based Models
Request Free Sample

Respiratory Care Devices Market Summary

The Respiratory Care Devices Market stood at an estimated USD 24.8 billion in 2025 and is projected to grow from USD 26.6 billion in 2026 to USD 52.3 billion by 2035, advancing at a CAGR of 7.8% across the forecast window. Growth is anchored to two concrete catalysts: expanded national screening programs for chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea, and reimbursement reforms in several OECD economies that now cover home-based ventilation and oxygen therapy. Hospitals remain the largest purchasing channel, but home care is closing the gap quickly.

It’s a gradual move from hospital-only bedside technology to portable, connected devices that patients can use outside of clinical settings. Manufacturers have invested much in smaller compressors, oxygen concentrators that are more efficient with batteries, and CPAP/BiPAP devices that share data—data on adherence, shared with care teams. Several national digital health programs are setting aside dedicated financing for remote respiratory monitoring infrastructure, highlighting the move from device-only sales to connected care ecosystems.

 

Regionally, North America leads with ~38% of the global sales due to the high prevalence of COPD/asthma and good reimbursement. Asia-Pacific is the fastest developing region due to increasing air pollution-related respiratory disorders and the building of hospital infrastructure. Europe is the second-largest market, spurred by its aging demography and the robustness of its public health screening programs. In the next decade, Asia-Pacific is likely to gradually gain unit volume market share, while North America will remain the leader in revenue.

 

Key Report Takeaways

• By Technology

  • CPAP and BiPAP systems represent the largest product category at 22% share of the Respiratory Care Devices Market
  • Oxygen concentrators are forecast to be among the fastest-expanding categories through 2035
  • Pulmonary function testing equipment is gaining share as early-diagnosis screening programs scale.

• By Sector

  • Hospitals & clinics account for an estimated 46% of the Respiratory Care Devices Market demand.
  • Home care settings are growing at a CAGR above the category average as patients shift to at-home therapy.
  • Ambulatory surgical centers contribute a smaller but steadily rising share of procurement.

• By Geography

  • North America commands roughly 38% of the global Respiratory Care Devices Market.
  • Asia-Pacific is forecast to post the fastest regional CAGR through 2035
  • Europe contributes the second-largest regional value base

Market Size and Forecast (2021–2035)

The figures below are based on publisher analysis of company filings, procurement data and national health expenditure databases and have been cross-checked against macro respiratory-disease prevalence patterns.

Respiratory Care Devices Market Size and Forecast
Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

Driver Impact Analysis

Driver ~% Impact on CAGR Geographic Relevance Impact Timeline
Rising COPD/asthma prevalence 22% Global Long-term
Aging population growth 18% NA, Europe, Japan Long-term
Homecare/telehealth adoption 16% Global Medium-term
Government screening programs 14% NA, EU, India Medium-term
Connected/portable device innovation 13% Global Short-term
Air pollution-linked disease burden 10% Asia-Pacific Long-term
Public health infrastructure investment 7% Emerging markets Short-term

 

Disease Burden and Screening Expansion

Several national health systems have widened COPD and sleep-apnea screening eligibility over the past two years, directly increasing diagnostic device procurement. The Global Initiative for Chronic Obstructive Lung Disease estimates COPD affects several hundred million people worldwide, and broader screening criteria in countries such as the UK and Germany have pushed forward diagnostic spirometer demand.

Homecare Shift and Reimbursement Reform

Reimbursement reform has been a decisive accelerant. U.S. Medicare policy updates expanding home oxygen and ventilator coverage, alongside comparable moves in parts of the EU, have shifted a meaningful share of purchasing from hospital capital budgets to home-health and durable medical equipment channels.

Connected Device Innovation

Manufacturers have prioritized Bluetooth- and cellular-enabled CPAP, oxygen concentrator, and ventilator platforms that stream adherence and physiological data to clinicians, supporting value-based care contracts that reward documented compliance over device sales alone.

Restraints Impact Analysis

Restraint impacts are directional estimates of downward pressure on growth and are not strictly additive.

Restraint ~% Impact on CAGR Geographic Relevance Impact Timeline
High device cost & reimbursement gaps -15% Emerging markets Medium-term
Lengthy regulatory approval cycles -11% Global Long-term
Device recalls & quality concerns. -9% NA, EU Short-term
Homecare staffing shortages -8% NA, Europe Medium-term
Component supply chain disruption -6% Global Short-term

 

Reimbursement and Affordability Gaps

In lower- and middle-income markets, out-of-pocket costs for oxygen concentrators and CPAP systems still exceed what most households can absorb without insurance support, slowing adoption even where prevalence data justify stronger demand.

Regulatory and Quality Friction

Tightened post-market surveillance requirements following past ventilator and CPAP recalls have lengthened approval timelines for new entrants, particularly in the EU under MDR transition requirements, creating a temporary drag on new product launches.

Respiratory Care Devices Market Opportunities

Connected Remote Monitoring

Cloud-linked respiratory devices that feed adherence and vital-sign data into clinician dashboards open recurring-revenue service contracts layered on top of hardware sales.

Emerging Market Expansion

India, Southeast Asia, and parts of Sub-Saharan Africa remain significantly underserved relative to disease burden, presenting long-run volume opportunity as public procurement programs scale local distribution.

Data and Subscription-Based Models

Respiratory-as-a-service contracts, bundling devices, consumables, and remote monitoring under a subscription fee, are emerging as an alternative to one-time capital purchases, particularly across hospital networks managing fleet-wide ventilator costs.

Home Sleep Apnea Testing Growth

Simplified at-home diagnostic kits are reducing dependence on overnight sleep-lab capacity, expanding the addressable population for downstream CPAP/BiPAP therapy.

AI-Enabled Diagnostics

Algorithmic analysis of spirometry and overnight oximetry data is improving early detection accuracy, creating a software attach opportunity alongside traditional hardware sales.

Respiratory Care Devices Market Future Outlook

AI-Enabled Predictive Monitoring

Predictive algorithms layered onto continuous oximetry and spirometry data are expected to shift care from reactive treatment toward early intervention, reducing acute exacerbation hospitalizations.

Platform and Subscription Economics

Device makers are increasingly bundling hardware, consumables, and data services into recurring contracts, mirroring broader medtech-as-a-service trends across the industry.

Sustainability and Device Lifecycle Management

Manufacturers face growing pressure to address device recyclability and battery lifecycle impact, particularly under EU sustainability reporting expectations affecting medical device producers.

Decentralization of Respiratory Care

The center of care continues moving from hospital wards to homes, supported by smaller, quieter, and more energy-efficient device designs suited to daily home use.

Respiratory Care Devices Market Segmentation

By Product Type

Segment Share (%) Primary Demand Driver
CPAP & BiPAP Systems 22% Rising sleep apnea diagnosis rates
Ventilation Support Devices 18% ICU and home care ventilator demand
Oxygen Concentrators 17% Portable home oxygen therapy growth
Nebulizers 15% Pediatric and asthma management demand
Pulmonary Function Testing 14% Expanded COPD screening programs
Other (Humidifiers, Accessories) 14% Consumables replacement cycles

 

CPAP and BiPAP systems lead the Respiratory Care Devices Market on the back of widening sleep-apnea diagnosis. At the same time, ventilation support devices retain a strong base from both critical-care and growing home-ventilation use cases.

By End User

Segment Share (%) Primary Demand Driver
Hospitals & Clinics 46% Critical care and surgical procedure volume
Homecare Settings 36% Reimbursement-supported home therapy
Ambulatory Surgical Centers 10% Outpatient procedure growth
Diagnostic Centers 8% Standalone pulmonary testing demand

 

Home care is the fastest-expanding end-user segment of the Respiratory Care Devices Market as payers increasingly favor lower-cost home-based management over extended hospital stays.

By Application

Segment Share (%) Primary Demand Driver
COPD 32% An aging population and pollution exposure
Obstructive Sleep Apnea 29% Rising diagnosis and awareness
Asthma 21% Pediatric and adult prevalence growth
Other Respiratory Disorders 18% Broader pulmonary disease screening

COPD leads respiratory application demand with a 32% share, driven by an aging population and rising pollution exposure. Obstructive sleep apnea follows closely at 29%, propelled by growing diagnosis rates and heightened awareness of the condition. Asthma accounts for 21% of the market amid increasing prevalence across both pediatric and adult populations, while other respiratory disorders (18%) benefit from the expanding scope of broader pulmonary disease screening.

Regional Market Share Analysis

Region Share (%) Primary Investment Themes
North America 38% Reimbursement-driven home care expansion
Europe 27% MDR compliance, aging population demand
Asia-Pacific 22% Pollution-linked disease burden, hospital build-out
South America 7% Public procurement program expansion
Middle East & Africa 6% Hospital infrastructure investment
Total 100% —

 

North America

Country Share of Region (%) Key Driver
United States 84% Medicare home-oxygen coverage expansion
Canada 11% Provincial home care funding
Mexico 5% Private hospital capacity growth

 

Demand in the United States continues to be shaped by CMS coverage policy for home respiratory equipment, while Canadian provinces have steadily widened durable medical equipment funding for COPD patients.

Europe

Country Share of Region (%) Key Driver
Germany 22% Statutory health insurance reimbursement
United Kingdom 18% NHS COPD screening expansion
France 14% Homecare service network growth
Rest of Europe 46% MDR-driven product modernization

 

Germany's statutory insurance framework continues to support relatively high per-capita device spending, while the UK's NHS long-term plan has expanded community-based respiratory screening.

Asia-Pacific

Country Share of Region (%) Key Driver
China 30% Hospital infrastructure expansion
Japan 20% An aging population demands
India 18% Public procurement scale-up
South Korea 12% Homecare reimbursement reform
Australia 8% Private insurance coverage growth
Rest of Asia-Pacific 12% Pollution-linked disease burden

 

China's continued hospital capacity build-out and India's national procurement initiatives are jointly pulling regional volume growth above the global average.

South America

Country Share of Region (%) Key Driver
Brazil 58% Public health system procurement
Rest of South America 42% Private hospital network growth

 

Brazil's public health system remains the dominant procurement channel, with growing private-sector participation in major urban centers.

Middle East & Africa

Country Share of Region (%) Key Driver
UAE 24% Private hospital investment
Saudi Arabia 22% Vision 2030 healthcare infrastructure spend
Rest of Middle East & Africa 54% NGO and donor-funded program expansion

 

Saudi Arabia's healthcare infrastructure investment under its national transformation program continues to support new hospital respiratory-unit procurement.

Respiratory Care Devices Market By Region, 2025-2035

Competitive Benchmarking

The Respiratory Care Devices Market is moderately concentrated, with the top five companies accounting for an estimated 45-55% of the global revenue market, with a long tail of regional and specialist manufacturers accounting for the rest.

Company Est. Revenue Share Range Key Offerings Strategic Positioning
Medtronic ~9–12% Ventilators, monitoring systems Hospital-focused portfolio breadth
ResMed ~8–11% CPAP, BiPAP, connected health platforms Homecare and digital-health leadership
Philips Respironics ~7–10% Sleep & respiratory devices Post-recall quality rebuild focus
Drägerwerk ~6–9% ICU ventilators, anesthesia systems Critical-care depth
GE Healthcare ~5–8% Hospital respiratory monitoring Integrated hospital systems
Fisher & Paykel Healthcare ~5–7% Humidification, nasal high-flow therapy Niche therapy innovation
Becton Dickinson ~4–6% Diagnostic and monitoring consumables Broad consumables distribution
Vyaire Medical ~3–5% Ventilators, diagnostics Mid-market hospital focus
Hamilton Medical ~3–5% Critical-care ventilators Specialty ICU ventilation
Invacare ~2–4% Homecare oxygen & mobility devices Homecare channel specialist

 

Recent News & Developments

  • ResMed (2024): Expanded its connected-CPAP data platform with broader clinician dashboard integration, reinforcing its subscription-style adherence monitoring model [18]
  • Philips (2023): Continued post-recall remediation and relaunch of sleep and respiratory devices under updated quality protocols [19]
  • Medtronic (2024): Announced portfolio expansion in portable ventilation aimed at home care and transport use cases [20]
  • Drägerwerk (2023): Introduced updated ICU ventilator software focused on lung-protective ventilation algorithms
  • U.S. CMS (2024): Updated home respiratory equipment coverage policy, broadening eligibility for oxygen therapy reimbursement [22]
  • Fisher & Paykel Healthcare (2025): Expanded nasal high-flow therapy manufacturing capacity to meet rising hospital demand
  • EU MDR (2024): Continued phased enforcement affecting respiratory device recertification timelines across European manufacturers
  • Vyaire Medical (2023): Entered a distribution partnership to expand ventilator access across Southeast Asian hospital networks

Respiratory Care Devices Market Report Scope

Item Detail
Market Scope Global Respiratory Care Devices Market by product, end user, application, and region
Study Period 2021–2035
CAGR 7.8% (2026–2035)
Market Size Checkpoints 2025 base year: USD 24.8B; 2035 forecast: USD 52.3B
Fastest Growing Segments Oxygen Concentrators (product); Homecare (end user)
Companies Profiled 10 leading global and regional manufacturers
Valuation Currency USD

 

FAQs

What should buyers prioritize when comparing respiratory device vendors?
Service and data-integration support matter as much as device specifications. Vendors offering remote monitoring and adherence reporting reduce long-term clinical workload [Ref 18].
How does MDR compliance affect procurement timelines in Europe?
Recertification under MDR has extended product launch timelines for several manufacturers. Buyers should confirm certification status before committing to multi-year contracts [Ref 19].
What integration challenges arise with connected respiratory devices?
Hospital IT systems often require custom interfaces to ingest device data. Procurement teams should evaluate interoperability standards before deployment [Ref 18].
Are subscription-based device models gaining traction?
Yes, bundled hardware-plus-monitoring contracts are emerging, especially in home care. They shift the cost from upfront capital to predictable recurring fees [Ref 21].
How does reimbursement policy vary by region for home care devices?
Coverage differs significantly; U.S. Medicare and several EU systems fund home oxygen, while many emerging markets still require out-of-pocket payment [Ref 20].
What competitive risks exist for smaller respiratory device manufacturers?
Smaller players face pricing pressure from consolidated leaders and rising regulatory compliance costs, making partnerships or niche specialization important [Ref 14].
What emerging use cases are expanding beyond traditional respiratory therapy?
Home sleep apnea testing and AI-assisted spirometry are extending device use into earlier-stage diagnosis, beyond established chronic-care management [Ref 10].  
Author
Author
Author Profile
Rahul Gotadki LinkedIn
Research Manager
He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.
Co-Author
Co-Author Profile
Kinjoll Dey LinkedIn
Senior Research Analyst
He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get In Touch

Research Approach

 

Secondary Research

The secondary research process involved comprehensive analysis of regulatory databases, clinical publications, medical device registries, and authoritative health organizations. Key sources included the US Food & Drug Administration (FDA) Center for Devices and Radiological Health (CDRH), European Medicines Agency (EMA) Medical Device Coordination Group (MDCG), International Organization for Standardization (ISO 80601 series for respiratory medical devices), Federal Aviation Administration (FAA) for portable oxygen device standards, and Transport Canada/Sante Canada for cross-border device regulations.

Clinical and epidemiological data were sourced from the Global Initiative for Chronic Obstructive Lung Disease (GOLD), Global Initiative for Asthma (GINA), American Thoracic Society (ATS), European Respiratory Society (ERS), American Academy of Sleep Medicine (AASM), American Association for Respiratory Care (AARC), British Thoracic Society (BTS), and the National Heart, Lung, and Blood Institute (NHLBI). Statistical databases included the Centers for Disease Control and Prevention (CDC) National Center for Health Statistics, CDC National Health and Nutrition Examination Survey (NHANES), World Health Organization (WHO) Global Health Observatory, WHO Global Tuberculosis Report, OECD Health Statistics, EU Eurostat Health Database, National Institutes of Health (NIH) National Library of Medicine (PubMed/MEDLINE), and ClinicalTrials.gov for investigational device trials.

Market landscape intelligence was gathered from proprietary medical device databases, healthcare procurement registries, and national health ministry reports from key markets (US CMS National Health Expenditure Accounts, NHS England Device Registry, Japan Ministry of Health Labour and Welfare Medical Device Statistics).

Device utilization statistics, regulatory 510(k) and PMA approval data, clinical safety studies, COPD/asthma prevalence trends, sleep apnea diagnostic rates, and competitive intelligence for ventilators, CPAP/BiPAP systems, oxygen concentrators, nebulizers, spirometers, and respiratory consumables were gathered from these sources.

 

Primary Research

Qualitative and quantitative insights were obtained by interviewing supply-side and demand-side stakeholders during the primary research process. The supply-side sources comprised CEOs, Business Unit Heads for Respiratory Care, Vice Presidents of R&D, Regulatory Affairs Directors, and Commercial Directors from therapeutic device manufacturers (ventilation, oxygen therapy, sleep apnea devices), monitoring device OEMs, and consumables suppliers. Board-certified pulmonologists, critical care specialists, sleep medicine physicians, respiratory therapists, clinical engineers, ICU directors, and procurement leads from acute care hospitals, long-term acute care facilities, home healthcare providers, ambulatory surgical centers, and emergency medical services comprised demand-side sources.

The primary research project confirmed the product pipeline timelines for portable ventilators and smart CPAP systems, validated market segmentation across device types (therapeutic, monitoring, diagnostic, consumables), and gathered insights on clinical adoption patterns, homecare transition trends, reimbursement dynamics (Medicare fee schedules, insurance coverage for sleep studies), and hospital capital equipment procurement cycles.

Primary Respondent Breakdown:

By Designation: C-level Primaries (32%), Director Level (31%), Others (37%)

By Region: North America (32%), Europe (30%), Asia-Pacific (28%), Rest of World (10%)

 

Market Size Estimation

Revenue mapping, device shipment analysis, and procedure volume extrapolation were implemented to determine the global market valuation. The methodology comprised the following:

Focused analysis of respiratory care specialists and diversified medical technology conglomerates, as well as the identification of 40+ key manufacturers across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa

Across therapeutic devices (invasive/non-invasive ventilators, CPAP/BiPAP systems, oxygen concentrators, liquid oxygen systems, nebulizers, humidifiers), monitoring devices (pulse oximeters, capnographs, peak flow meters), diagnostic devices (spirometers, polysomnography systems, sleep screening devices), and consumables (ventilator circuits, oxygen masks, nasal cannulas, CPAP masks, filters), the following is a product mapping.

An examination of the annual revenues of respiratory care portfolios, with a focus on acute care and homecare settings, as reported and modeled.

Manufacturers that account for 65-70% of the global market share in 2024 are included in the coverage.

Extrapolation is employed to derive segment-specific valuations for each device category and application area (COPD, asthma, sleep apnea, respiratory distress syndrome) by combining bottom-up (device unit sales × ASP by country/region, procedure volumes for sleep studies, COPD exacerbation hospitalizations) and top-down (manufacturer revenue validation, distributor markup analysis) approaches.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

No regional reports available for this market.

Customer Stories

Case Study Cover Image
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.